- Radboud Repository
- →
- Browsing by Author
JavaScript is disabled for your browser. Some features of this site may not work without it.
Browsing by Author "Koopmans, P.P."
Now showing items 1-50 of 215
-
Gender differences in the use of cardiovascular interventions in HIV-positive persons; the D:A:D Study Hatleberg, C.I.; Ryom, L.; El-Sadr, W.; Mocroft, A.; Reiss, P.; Wit, S. de; Dabis, F.; Pradier, C.; Monforte, A.; Kovari, H.; et al.2018, Article / Letter to editor (Journal of the International AIDS Society, vol. 21, iss. 3, (2018), article e25083)
sine al.
-
-
Soluble TLR2 and 4 concentrations in cerebrospinal fluid in HIV/SIV-related neuropathological conditions ; ; ; Stelma, F.F.; Burm, S.; Bajramovic, J.; ; ; ; Koopman, G.; et al.2017, Article / Letter to editor (Journal of Neurovirology, vol. 23, iss. 2, (2017), pp. 250-259)
sine al.
-
-
Boceprevir, peginterferon and ribavirin for acute hepatitis C in HIV infected patients Hullegie, S.J.; Claassen, M.A.; Berk, G.E. van den; Meer, J.T. van der; Posthouwer, D.; Lauw, F.N.; Leyten, E.M.; ; Richter, C.; Eeden, A. van; et al.2016, Article / Letter to editor (Journal of Hepatology, vol. 64, iss. 4, (2016), pp. 807-812)
sine al.
-
-
Acute hepatitis C in the Netherlands: characteristics of the epidemic in 2014 Hullegie, S.J.; Berk, G.E. van den; Leyten, E.M.; Arends, J.E.; Lauw, F.N.; Meer, J.T. van der; Posthouwer, D.; Eeden, A. van; ; Richter, C.; et al.2016, Article / Letter to editor (Clinical Microbiology and Infection, vol. 22, iss. 2, (2016), pp. 209.e1-3)
sine al.
-
Factors associated with presenting late or with advanced HIV disease in the Netherlands, 1996-2014: results from a national observational cohort Coul, E.L. Op de; Sighem, A. van; Brinkman, K.; Benthem, B.H. van; Ende, M.E. van der; Geerlings, S.; Reiss, P.; ; ; ; et al.2016, Article / Letter to editor (BMJ Open, vol. 6, iss. 1, (2016), pp. e009688)
sine al.
-
Virological and Social Outcomes of HIV-Infected Adolescents and Young Adults in The Netherlands Before and After Transition to Adult Care Weijsenfeld, A.M.; Smit, C.; Cohen, S.; Wit, F.W.; Mutschelknauss, M.; Knaap, L.C. van der; Zonneveld, L.M. van; Zomer, B.J.; Nauta, N.; Patist, J.C.; et al.2016, Article / Letter to editor (Clinical Infectious Diseases, vol. 63, iss. 8, (2016), pp. 1105-1112)
sine al.
-
-
-
-
Diminished Impact of Ethnicity as a Risk Factor for Chronic Kidney Disease in the Current HIV Treatment Era Schoffelen, A.F.; Smit, C.; Lelyveld, S.F. van; Vogt, L.; Bauer, M.P.; Reiss, P.; Hoepelman, A.I.; Barth, R.E.; ; ; et al.2015, Article / Letter to editor (The Journal of Infectious Diseases, vol. 212, iss. 2, (2015), pp. 264-274)
sine al.
-
-
-
Risk of non-AIDS-defining events among HIV-infected patients not yet on antiretroviral therapy Zhang, S.; Sighem, A. van; Kesselring, A.; Gras, L.; Prins, J.M.; Hassink, E.; Kauffmann, R.; Richter, C.; Wolf, F. de; Reiss, P.; et al.2015, Article / Letter to editor (Hiv Medicine, vol. 16, iss. 5, (2015), pp. 265-272)
sine al.
-
Increased virological failure in naive HIV-1-infected patients taking lamivudine compared with emtricitabine in combination with tenofovir and efavirenz or nevirapine in the Dutch nationwide ATHENA cohort Rokx, C.; Fibriani, A.; Vijver, D.A. van de; Verbon, A.; Schutten, M.; Gras, L.; Rijnders, B.J.; ; ; ; et al.2015, Article / Letter to editor (Clinical Infectious Diseases, vol. 60, iss. 1, (2015), pp. 143-153)
sine al.
-
-
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration Smith, C.J.; Ryom, L.; Weber, R.; Morlat, P.; Pradier, C.; Reiss, P.; Kowalska, J.D.; Wit, S. de; Law, M.; Sadr, W. el; et al.2014, Article / Letter to editor (The Lancet (London), vol. 384, iss. 9939, (2014), pp. 241-248)
sine al.
-
Increased risk of cardiovascular disease (CVD) with age in HIV-positive men: a comparison of the D:A:D CVD risk equation and general population CVD risk equations Petoumenos, K.; Reiss, P.; Ryom, L.; Rickenbach, M.; Sabin, C.A.; El-Sadr, W.; Monforte, A.; Phillips, A.N.; Wit, S. de; Kirk, O.; et al.2014, Article / Letter to editor (Hiv Medicine, vol. 15, iss. 10, (2014), pp. 595-603)
sine al.
-
-
Development of a definition for Rapid Progression (RP) of renal function in HIV-positive persons: the D:A:D study Kamara, D.A.; Ryom, L.; Ross, M.; Kirk, O.; Reiss, P.; Morlat, P.; Moranne, O.; Fux, C.A.; Mocroft, A.; Sabin, C.; et al.2014, Article / Letter to editor (BMC Nephrology, vol. 15, (2014), pp. 51)
sine al.
-
-
-
Lower incidence of Pneumocystis jirovecii pneumonia among Africans in the Netherlands host or environmental factors? Schoffelen, A.F.; Lelyveld, S.F. van; Barth, R.E.; Gras, L.; Wolf, F. de; ; Hoepelman, A.I.; ; ; ; et al.2013, Article / Letter to editor (Aids, vol. 27, iss. 7, (2013), pp. 1179-1184)
sine al.
-
Association between antiretroviral exposure and renal impairment among HIV-positive persons with normal baseline renal function: the D:A:D study. Ryom, L.; Mocroft, A.; Kirk, O.; Worm, S.W.; Kamara, D.A.; Reiss, P.; Ross, M.; Fux, C.A.; Morlat, P.; Moranne, O.; et al.2013, Article / Letter to editor (vol. 207, iss. 9, (2013), pp. 1359-1369)
sine al.
-
Changes in first-line cART regimens and short-term clinical outcome between 1996 and 2010 in The Netherlands Smit, M. de; ; Geerlings, S.; Gras, L.; Brinkman, K.; Hallett, T.B.; Wolf, F. de; ; ; ; et al.2013, Article / Letter to editor (PLoS One, vol. 8, iss. 9, (2013), article e76071)
sine al.
-
-
Temporary antiretroviral treatment during primary HIV-1 infection has a positive impact on health-related quality of life: data from the Primo-SHM cohort study Grijsen, M.; Koster, G.; van Vonderen, M.; ; Kootstra, G.; Steingrover, R.; de Wolf, F.; Prins, J.M.; Nieuwkerk, P.T.; ; et al.2012, Article / Letter to editor (Hiv Medicine, vol. 13, iss. 10, (2012), pp. 630-635)
sine al.
-
-
-
Long-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohort. Lelyveld, S.F. van; Gras, L.; Kesselring, A.; Zhang, S.; Wolf, F. de; Wensing, A.M.; Hoepelman, A.I.; ; ; ; et al.2012, Article / Letter to editor (Aids, vol. 26, iss. 4, (2012), pp. 465-474)
sine al.
-
No treatment versus 24 or 60 weeks of antiretroviral treatment during primary HIV infection: the randomized Primo-SHM trial. Grijsen, M.L.; Steingrover, R.; Wit, F.W.; Jurriaans, S.; Verbon, A.; Brinkman, K.; Ende, M.E. van der; Soetekouw, R.; Wolf, F. de; Lange, J.M.A.; et al.2012, Article / Letter to editor (Plos Medicine, vol. 9, iss. 3, (2012), pp. e1001196)
sine al.
-
-
When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study Cain, L.E.; Logan, R.; Robins, J.M.; Sterne, J.A.; Sabin, C.; Bansi, L.; Justice, A.; Goulet, J.; Sighem, A. van; Wolf, F. de; et al.2011, Article / Letter to editor (Annals of Internal Medicine C.2, vol. 154, iss. 8, (2011), pp. 509-515)
sine al.
-
Lower mortality and earlier start of combination antiretroviral therapy in patients tested repeatedly for HIV than in those with a positive first test Gras, L.; Sighem, A. van; Bezemer, D.; ; Wit, F.; Wolf, F. de; ; ; ; ; et al.2011, Article / Letter to editor (Aids, vol. 25, iss. 6, (2011), pp. 813-818)
sine al.
-
The comparison of the performance of two screening strategies identifying newly-diagnosed HIV during pregnancy Boer, K.; ; ; Wolf, F. de; ; ; ; ; ; Post, F.; et al.2011, Article / Letter to editor (European Journal of Public Health, vol. 21, iss. 5, (2011), pp. 632-637)
sine al.
-
-
Immunovirological response to triple nucleotide reverse-transcriptase inhibitors and ritonavir-boosted protease inhibitors in treatment-naive HIV-2-infected patients: The ACHIEV2E Collaboration Study Group Benard, A.; Sighem, A. van; Taieb, A.; Valadas, E.; Ruelle, J.; Soriano, V.; Calmy, A.; Balotta, C.; Damond, F.; Brun-Vezinet, F.; et al.2011, Article / Letter to editor (Clinical Infectious Diseases, vol. 52, iss. 10, (2011), pp. 1257-1266)
sine al.
-
Impact of the HIV-1 env genetic context outside HR1-HR2 on resistance to the fusion inhibitor enfuvirtide and viral infectivity in clinical isolates Baatz, F.; Nijhuis, M.; Lemaire, M.; Riedijk, M.; Wensing, A.M.; Servais, J.Y.; Ham, P.M. van; Hoepelman, A.I.; ; Sprenger, H.G.; et al.2011, Article / Letter to editor (PLoS One, vol. 6, iss. 7, (2011), article e21535)
sine al.
-
-
-
-
Abacavir/lamivudine/zidovudine maintenance after standard induction in antiretroviral therapy-naive patients: FREE randomized trial interim results. Sprenger, H.G.; Langebeek, N.; Mulder, P.G.; Napel, C.H.H. ten; Vriesendorp, R.; Hoepelman, A.I.; Legrand, J.C.; ; ; Bravenboer, B.; et al.2010, Article / Letter to editor (AIDS Patient Care and Stds, vol. 24, iss. 6, (2010), pp. 361-366)
sine al.
-
Transmission networks of HIV-1 among men having sex with men in the Netherlands. Bezemer, D.; Sighem, A. van; Lukashov, V.V.; Hoek, L. van der; Back, N.; Schuurman, R.; Boucher, C.A.B.; Claas, E.C.; Boerlijst, M.C.; Coutinho, R.A.; et al.2010, Article / Letter to editor (Aids, vol. 24, iss. 2, (2010), pp. 271-282)
sine al.
-
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. Ray, M.; Logan, R.; Sterne, J.A.; Hernadez-Diaz, S.; Robins, J.M.; Sabin, C.; Bansi, L.; Sighem, A. van; Wolf, F. de; Costagliola, D.; et al.2010, Article / Letter to editor (Aids, vol. 24, iss. 1, (2010), pp. 123-137)
sine al.
-
-
-
Variable impact on mortality of AIDS-defining events diagnosed during combination antiretroviral therapy: not all AIDS-defining conditions are created equal. Mocroft, A.; Sterne, J.A.; Egger, M.; May, M.; Grabar, S.; Furrer, H.; Sabin, C.; Fatkenheuer, G.; Justice, A.; Reiss, P.; et al.2009, Article / Letter to editor (Clinical Infectious Diseases, vol. 48, iss. 8, (2009), pp. 1138-1151)
sine al.
-
Now showing items 1-50 of 215
Upload Full Text